// App-Quantinova.ai

15440 : Bleeding Complications May Outweigh the Risk of Thrombosis in Patients With End-stage Liver Disease Taking Dual Antiplatelet Therapy After Percutaneous Coronary Intervention

Researchers

Presenter

  • Sami J Natour

Principal Investigators

  • May Myint Thanda Kyaw

  • Ronald W Busuttil

  • Jonathan M Tobis

  • Henry M Honda

Medical Centers

  • Medicine, Dept of Medicine, Univ of California Los Angeles, Los Angeles, CA

  • Medicine/Cardiology, David Geffen School of Medicine at UCLA, Los Angeles, CA

  • Dept of Neurology, Univ of California, Los Angeles, Los Angeles, CA

  • Medicine, Div of Cardiology, Div of Cardiology, Univ of California Los Angeles, Los Angeles, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • End-stage liver disease

  • Myocardial infarction

  • Restenosis

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved